Katerina Growkova

Ostrava, MO, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.

Journal: Blood advances

Published: November 23, 2020

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.

Journal: Haematologica

Published: October 08, 2019

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination.

Journal: Leukemia

Published: May 02, 2019

Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).

Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).

Journal: American journal of hematology

Published: October 17, 2018

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing.

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing.

Journal: Journal of clinical pathology

Published: December 21, 2017

Active site alanine mutations convert deubiquitinases into high-affinity ubiquitin-binding proteins.

Active site alanine mutations convert deubiquitinases into high-affinity ubiquitin-binding proteins.

Journal: EMBO reports

Published: December 20, 2017

Venetoclax: A new wave in hematooncology.

Venetoclax: A new wave in hematooncology.

Journal: Experimental hematology

Published: November 13, 2017

Biomarkers in Immunoglobulin Light Chain Amyloidosis.

Biomarkers in Immunoglobulin Light Chain Amyloidosis.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: September 15, 2017

Diagnostic Tools of Waldenströms Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring.

Diagnostic Tools of Waldenströms Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: September 15, 2017

CRISPR in Research and Treatment of Multiple Myeloma.

CRISPR in Research and Treatment of Multiple Myeloma.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: September 15, 2017

Whole Exome Sequencing of Aberrant Plasma Cells in a Patient with Multiple Myeloma Minimal Residual Disease.

Whole Exome Sequencing of Aberrant Plasma Cells in a Patient with Multiple Myeloma Minimal Residual Disease.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: September 15, 2017

Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.

Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.

Journal: European journal of haematology

Published: August 22, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026